PharmaShots | Incisive News in 3 Shots

Subscribe Now

decrease

G1 Therapeutics' Cosela (trilaciclib) Receives US FDA's Approval as the First Myeloprotection Therapy for Extensive-Stage Small Cell Lung Cancer

G1 Therapeutics' Cosela (trilaciclib) Receives US FDA's Approval as the First Myeloprotection Therapy for Extensive-Stage Small Ce...

February 15, 2021

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

November 5, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us